Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome : The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

Introduction. Retrospective observational data show that ACE-inhibitor therapy delays renal failure and improves life expectancy in Alport patients with proteinuria. The EARLY PRO-TECT Alport trial assesses the safety and efficacy of early therapy onset with ramipril in pediatric Alport patients. Me...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ISRN pediatrics 2012, Vol.2012 (2012), p.1-6
Hauptverfasser:	Gross, Oliver, Friede, Tim, Hilgers, Reinhard, Görlitz, Anke, Gavénis, Karsten, Ahmed, Raees, Dürr, Ulrike
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Study
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!